Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
KSQ Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
KSQ Therapeutics

KSQ Therapeutics

KSQ Therapeutics: A Massachusetts-based biotech firm specializing in precision genomics and disease treatment.

HQ
Cambridge, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

KSQ Therapeutics is a Massachusetts-based biotechnology company focused on discovering and developing transformative medicines using precision genomics. Leveraging their proprietary CRISPRomics® platform, they aim to identify top therapeutic targets with curative potential. Their core mission is to tackle the toughest challenges in medicine, particularly in cancer treatment, through advanced CRISPR/Cas9-engineered Tumor Infiltrating Lymphocytes (eTIL®) programs.

KSQ Therapeutics has made significant strides in the biotech industry, advancing a robust pipeline of first-in-class candidates and partnered programs. Their innovative approach has positioned them as a leader in precision functional genomics, contributing to the development of potentially curative therapies. Their work has garnered attention and support from notable investors and industry leaders, reinforcing their impact on the future of medicine.

KSQ Therapeutics - Similar Companies

NKT Therapeutics logo

NKT Therapeutics

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Quanta Therapeutics logo

Quanta Therapeutics

quantatx.com

Alphina Therapeutics logo

Alphina Therapeutics

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

K36 Therapeutics logo

K36 Therapeutics

k36tx.com

Encoded Therapeutics logo

Encoded Therapeutics

CAMP4 Therapeutics logo

CAMP4 Therapeutics

camp4tx.com

Moma Therapeutics logo

Moma Therapeutics

Fore Biotherapeutics logo

Fore Biotherapeutics

fore.bio

RootPath Genomics logo

RootPath Genomics

rootpath.com

Kestrel Therapeutics logo

Kestrel Therapeutics

Scorpion Therapeutics logo

Scorpion Therapeutics

Kezar Life Sciences logo

Kezar Life Sciences

KSQ Therapeutics - Quick Facts

Who are KSQ Therapeutics' competitors?

Companies similar to KSQ Therapeutics include NKT Therapeutics, Nested Therapeutics, Celsius Therapeutics and Quanta Therapeutics.

When was KSQ Therapeutics founded?

KSQ Therapeutics was founded in 2015.

Where is KSQ Therapeutics' headquarters located?

KSQ Therapeutics' headquarters is located in Cambridge, MA, US.

When was KSQ Therapeutics' last funding round?

KSQ Therapeutics' most recent funding round was for $80M (USD) in September 2018.

How much has KSQ Therapeutics raised to-date?

As of Sep 28, 2018, KSQ Therapeutics has raised a total of $156M (USD).

How many employees does KSQ Therapeutics have?

KSQ Therapeutics has 85 employees as of Feb 5, 2024.

KSQ Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • GenAI
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medicines
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified